Related Experiment Video
Updated: Feb 28, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Role of ESCRT component HD-PTP/PTPN23 in cancer
Marie-Claude Gingras1,2, Jalal M Kazan1,2, Arnim Pause3,2
1Department of Biochemistry, McGill University, Montréal, Québec, Canada H3G 1Y6.
Abstract:
Sustained cellular signalling originated from the receptors located at the plasma membrane is widely associated with cancer susceptibility. Endosomal sorting and degradation of the cell surface receptors is therefore crucial to preventing chronic downstream signalling and tumorigenesis. Since the Endosomal Sorting Complexes Required for Transport (ESCRT) controls these processes, ESCRT components were proposed to act as tumour suppressor genes. However, the bona fide role of ESCRT components in tumorigenesis has not been clearly demonstrated. The ESCRT member HD-PTP/PTPN23 was recently identified as a novel haplo-insufficient tumour suppressor in vitro and in vivo, in mice and humans. In this mini-review, we outline the role of the ESCRT components in cancer and summarize the functions of HD-PTP/PTPN23 in tumorigenesis.
Insights
Endosomal Sorting Complexes Required for Transport (ESCRT) components regulate cell signaling to prevent cancer. The ESCRT member HD-PTP/PTPN23 acts as a tumor suppressor, highlighting ESCRT
Area of Science:
- Cellular Biology
- Molecular Oncology
- Biochemistry
Background:
- Sustained cell signaling from plasma membrane receptors is linked to cancer.
- Endosomal sorting and degradation of cell surface receptors are vital for preventing chronic signaling and tumorigenesis.
- The Endosomal Sorting Complexes Required for Transport (ESCRT) machinery controls these receptor trafficking processes.
Purpose of the Study:
- To review the role of ESCRT components in cancer.
- To summarize the functions of HD-PTP/PTPN23 in tumorigenesis.
- To clarify the bona fide role of ESCRT components in cancer development.
Main Methods:
- Literature review of ESCRT function in cancer.
- Analysis of studies on HD-PTP/PTPN23 in vitro and in vivo.
- Summary of evidence for ESCRT components as tumor suppressors.
Main Results:
- ESCRT components are proposed tumor suppressors due to their role in receptor regulation.
- HD-PTP/PTPN23 is identified as a novel haplo-insufficient tumor suppressor.
- Evidence supports the involvement of ESCRT in preventing chronic signaling and tumorigenesis.
Conclusions:
- ESCRT machinery plays a critical role in regulating cell surface receptors and preventing cancer.
- HD-PTP/PTPN23 functions as a tumor suppressor, underscoring the importance of ESCRT in cancer prevention.
- Further research into ESCRT components can reveal new therapeutic strategies for cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

